台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    50.3
  • 漲跌
    ▼1.5
  • 漲幅
    -2.90%
  • 成交量
    219
  • 產業
    上市 生技醫療類股
  • 128人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
和康生 (1783)籌碼相關-元富-大裕 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-大裕 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2100.00651.7551.80-6233-2.57%
2025/01/17549.80549.7749.8002280.00%
2025/01/15950.67349.3249.3062222.70%
2025/01/13152.20152.6052.0002080.00%
2025/01/10153.20152.5051.7001980.00%
2025/01/0300.00049.1550.100146-0.01%
2025/01/02049.0500.0049.0001370.00%
2024/12/26046.7500.0046.9001280.00%
2024/12/11049.05049.1048.6501210.00%
2024/12/10046.600.146.8046.70-0.1106-0.05%
2024/12/06045.95046.2046.2001050.00%
2024/12/05045.9500.0046.0001020.00%
2024/12/04045.1000.0045.9501010.00%
2024/11/11042.850.243.2043.60-0.1116-0.13%
2024/11/0700.00141.8042.15-1115-0.86%
2024/10/30042.1500.0042.3001360.00%
2024/10/29042.6000.0042.3001380.00%
2024/10/25042.1000.0042.4501400.00%
2024/10/1500.00142.9042.80-1217-0.46%
2024/09/1900.003.244.0343.90-3.2390-0.82%
2024/08/19043.7500.0043.8004270.00%
2024/08/15042.9500.0043.2004250.00%
2024/08/1400.00543.3643.20-5425-1.18%
2024/08/1300.00142.5043.10-1425-0.23%
2024/07/23045.5500.0045.5503930.00%
2024/07/22146.5000.0046.5013910.26%
2024/07/19248.3000.0046.5023840.52%
2024/07/16345.0000.0044.7533280.91%
2024/07/0900.00446.0344.05-4329-1.22%
2024/07/08147.2000.0047.0013110.32%
2024/07/04149.5000.0049.5512950.34%
2024/07/03550.82250.4550.4032841.05%
2024/07/026.550.9500.0050.406.52622.46%
2024/06/2600.000.346.7046.85-0.3179-0.19%
2024/06/24046.2500.0046.0501710.00%
2024/06/20046.2500.0045.9501680.00%
2024/06/18046.00145.7046.35-1165-0.60%
2024/06/17144.9500.0045.2511590.63%
2024/06/07045.300.345.5545.60-0.3155-0.19%
2024/06/060.144.80144.7544.90-0.9154-0.58%
2024/06/05145.3000.0044.9011530.66%
2024/05/30042.5000.0042.2001400.01%
2024/05/28042.3500.0042.5501410.01%
2024/05/20043.6000.0043.8001360.01%
2024/05/17043.2200.0043.6001350.00%
2024/05/16043.1000.0043.1501340.01%
2024/05/14043.6000.0043.2001400.01%
2024/05/13043.0100.0043.5501420.01%
2024/05/03042.8500.0042.9001540.01%
2024/04/22042.4500.0042.3501630.00%
2024/04/16143.4000.0043.3511610.62%
2024/04/10046.2500.0046.1001630.01%
2024/04/0300.00046.7546.000163-0.02%
2024/04/02147.3000.0046.3011650.60%
2024/03/29145.6000.0045.7011640.61%
2024/03/28046.0500.0045.7001660.01%
2024/03/27045.5000.0045.8001660.01%
2024/03/26045.6100.0045.3501670.02%
2024/03/22045.10145.1545.00-1166-0.59%
2024/03/210.144.95145.1044.95-0.9167-0.54%
2024/03/200.844.9000.0044.900.81670.46%
2024/03/1900.00244.9544.90-2166-1.20%
2024/03/1800.00144.8545.60-1166-0.60%
2024/03/13044.7500.0044.7001660.01%
2024/03/12045.3000.0045.6001660.00%
2024/02/23047.5500.0046.9001790.00%
2024/02/20047.6000.0047.6001900.01%
2024/02/19048.2000.0048.0501900.00%
2024/02/01045.7000.0045.7501820.01%
2024/01/31045.5000.0045.5001820.00%
2024/01/25145.0000.0045.0011830.54%
2024/01/24045.5500.0045.6501830.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章